A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
Public ClinicalTrials.gov record NCT05260541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is comprised of a 4-week randomized, double-blind, placebo-controlled treatment period followed by an optional 8-week open-label extension (OLE) period. This trial will evaluate the efficacy and safety of oral PRAX-114 flexibly dosed at 40 to 60 mg for 4 weeks compared to placebo in adults with PTSD. The OLE period consisting of treatment with 40 mg PRAX-114 for 8 weeks will provide additional efficacy and safety data.
Study identification
- NCT ID
- NCT05260541
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 11 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2022
- Primary completion
- Jul 31, 2022
- Completion
- Sep 22, 2022
- Last update posted
- Nov 30, 2022
2022
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Praxis Research Site | Phoenix | Arizona | 85012 | — |
| Praxis Research Site | Little Rock | Arkansas | 72211 | — |
| Praxis Research Site | Rogers | Arkansas | 72758 | — |
| Praxis Research Site | Lemon Grove | California | 91945 | — |
| Praxis Research Site | Westlake Village | California | 91362 | — |
| Praxis Research Site | Fort Myers | Florida | 33908 | — |
| Praxis Research Site | Decatur | Georgia | 30030 | — |
| Praxis Research Site | Boston | Massachusetts | 02131 | — |
| Praxis Research Site | Las Vegas | Nevada | 89102 | — |
| Praxis Research Site | Cincinnati | Ohio | 45219 | — |
| Praxis Research Site | Dayton | Ohio | 45417 | — |
| Praxis Research Site | Oklahoma City | Oklahoma | 73118 | — |
| Praxis Research Site | Allentown | Pennsylvania | 18104 | — |
| Praxis Research Site | Media | Pennsylvania | 19063 | — |
| Praxis Research Site | Austin | Texas | 78737 | — |
| Praxis Research Site | Dallas | Texas | 75231 | — |
| Praxis Research Site | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05260541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2022 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05260541 live on ClinicalTrials.gov.